-
Reporting Standards in Predictive Modeling of Cancer Outcomes: An Umbrella Review of Adherence to the TRIPOD SR MA Reporting Guideline
Mar 10, 2025, 14:00 PM -
Benchmarking Duration of Injectable Medication Use: How do Claim Intervals Compare with Days Supply in the Real World?
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of CT Colonography Under Real-World Colorectal Cancer Screening Adherence
Mar 10, 2025, 14:00 PM -
Follow Me, If You Can: How Tokenized Linkage Extends Patient Observations in Real-World Databases - the Komodo Research Dataset Example
Mar 10, 2025, 14:00 PM -
Assessing the Comorbidity Burden of Ehlers-Danlos Syndromes (EDS): An Analysis Using US Real-World Data
Mar 10, 2025, 14:00 PM -
Evaluating the Economic and Environmental Impact of Reprocessed IPC Sleeves for VTE Prophylaxis: a Cost-Consequence Analysis
Mar 10, 2025, 14:00 PM -
Trends in Use of Cost-Minimization Analyses in CDA-AMC Reimbursement Submissions
Mar 10, 2025, 14:00 PM -
Determination of Medication Regimen Complexity Trends in Older Adult Patients With Insomnia: A Triangulation of Findings From Artificial Neural Network and Logistic Regression Analyses
Mar 10, 2025, 14:00 PM -
Evaluation of Measurement Properties of Health Assessment Questionnaire Disability Index (HAQ-DI) among Gout Populations in China
Mar 10, 2025, 14:00 PM -
Treatment Patterns and Healthcare Resource Use (HRU) in Patients With Metastatic Melanoma (mMEL) Treated With BRAF-MEK Inhibitor Targeted Therapies (TTs)
Mar 10, 2025, 14:00 PM -
Economic and Healthcare Burden in Patients with Sjögren's Syndrome: A Systematic Review
Mar 10, 2025, 14:00 PM -
The Cost Burden of Infertility Therapy for Women with a History of Hysteroscopic Adhesiolysis Compared to Those with Other or no Previous Intrauterine Surgery
Mar 10, 2025, 14:00 PM -
Late-Stage Outcomes in Patients with Limb-Girdle Muscular Dystrophy (LGMD) Sarcoglycanopathy Subtypes: A Systematic Review
Mar 10, 2025, 14:00 PM -
Review of Cell Therapy Access Landscape
Mar 10, 2025, 14:00 PM -
What Non-Profit Development of Pretomanid Can Teach About Paths to Innovation and Global Access to Treatments for Diseases of Poverty?
Mar 10, 2025, 14:00 PM -
Clinical Effectiveness and Safety of Reference and Biosimilar G-CSF As Primary Prophylaxis in DLBCL
Mar 10, 2025, 14:00 PM -
Economics of Prostate Cancer in Canada: A Systematic Review
Mar 10, 2025, 14:00 PM -
Reviewing Current Trends Regarding Use of Artificial Intelligence in Generating Real-World Evidence From Patient Medical Charts
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis and Value-Based Pricing of Digital Therapeutics for Pulmonary Rehabilitation in Patients With Chronic Respiratory Disease: A Multicenter Randomized Controlled Trial
Mar 10, 2025, 14:00 PM -
Comparing Hospital Prices Paid by Commercial Insurance Plans at 340B vs. Non-340B Hospitals: Implications for Employers and Patients
Mar 10, 2025, 14:00 PM
